Novel g-C3N4/PrFeO3 nanocomposites with Z-scheme structure and superior photocatalytic activity toward visible-light-driven removal of tetracycline antibiotics

Heliyon. 2023 Nov 7;9(11):e22038. doi: 10.1016/j.heliyon.2023.e22038. eCollection 2023 Nov.

Abstract

In the presented work, heterostructured nanocomposites based on g-C3N4 and PrFeO3 with different mass content of PrFeO3 (0-10 wt%) were prepared by ultrasonic processing to study their photocatalytic activity in the process of antibiotic degradation under visible light. The study of phase composition, structural, morphological and textural characteristics carried out by powder X-ray diffraction, scanning electron microscopy and adsorption-structural analysis confirmed the presence of two phases - graphite-like C3N4 and orthorhombic PrFeO3 with average crystallite sizes of 5 and 21 nm and mesoporous structure with specific surface area of 57.2-68.6 m2/g and average pore size of 20 nm. The measured values of the forbidden bandwidth for the obtained nanocomposites were ∼3 eV, indicating potential activity under visible light irradiation. The efficiency of antibiotic removal under visible light was evaluated in the degradation of TCHCl. It was found that 5 % PrFeO3 content was optimal and increased the TOF by 5 times compared to pure g-C3N4. The results of photocatalytic test with absorbers showed that photocatalysis occurs by Z-scheme mechanism. The results obtained allow us to consider this nanocomposite as an effective and stable photocatalyst for pharmaceutical wastewater treatment.

Keywords: G-C3N4; Photocatalytic degradation; PrFeO3; Tetracycline hydrochloride; Z-scheme heterojunction.